Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Woltering

Showing results (351-360 of 430) with videos related to

Pageof 43
Sort By:
Neuropharmacology|April 15, 2004
Pharmacological manipulation of mGlu2 receptors influences cognitive performance in the rodentGuy A Higgins, Theresa M Ballard, James N C Kew, et al.
Surgery|October 30, 2012
Neurokinin A levels predict survival in patients with stage IV well differentiated small bowel neuroendocrine neoplasmsAnne E Diebold, J Philip Boudreaux, Yi-Zarn Wang, et al.
Cancers|January 18, 2020
Outcomes of Capecitabine and Temozolomide (CAPTEM) in Advanced Neuroendocrine Neoplasms (NENs)Katharine Thomas, Brianne A Voros, Meghan Meadows-Taylor, et al.
British Journal of Cancer|July 20, 2001
Growing vascular endothelial cells express somatostatin subtype 2 receptorsJ C Watson, D A Balster, B M Gebhardt, et al.
Experimental Aging Research|February 9, 2023
Working Memory Precision and Associative Binding in Mild Cognitive ImpairmentYajun Jia, Steven Woltering, Nicolaas E P Deutz, et al.
Bioorganic & Medicinal Chemistry Letters|April 1, 2008
Synthesis and characterization of 1,3-dihydro-benzo[b][1,4]diazepin-2-one derivatives: Part 3. New potent non-competitive metabotropic glutamate receptor 2/3 antagonistsThomas J Woltering, Jürgen Wichmann, Erwin Goetschi, et al.
Health Physics|February 20, 1999
Experiences with high dose radiopeptide therapy: the health physics perspectiveG D Espenan, J A Nelson, D R Fisher, et al.
Pancreas|July 29, 2010
NANETS consensus guidelines for the diagnosis of neuroendocrine tumorAaron I Vinik, Eugene A Woltering, Richard R P Warner, et al.
Pancreas|November 1, 2005
Effect of octreotide LAR dose and weight on octreotide blood levels in patients with neuroendocrine tumorsEugene A Woltering, Paris M Mamikunian, Stanley Zietz, et al.
Journal of the American College of Surgeons|March 26, 2013
An extended phase II trial of iodine-125 methylene blue for sentinel lymph node identification in women with breast cancerWilliam W Harkrider, Anne E Diebold, Thomas Maloney, et al.
Pageof 43

Showing results (351-360 of 430) with videos related to

Sort By:
Pageof 43
Neuropharmacology|April 15, 2004
Pharmacological manipulation of mGlu2 receptors influences cognitive performance in the rodentGuy A Higgins, Theresa M Ballard, James N C Kew, et al.
Surgery|October 30, 2012
Neurokinin A levels predict survival in patients with stage IV well differentiated small bowel neuroendocrine neoplasmsAnne E Diebold, J Philip Boudreaux, Yi-Zarn Wang, et al.
Cancers|January 18, 2020
Outcomes of Capecitabine and Temozolomide (CAPTEM) in Advanced Neuroendocrine Neoplasms (NENs)Katharine Thomas, Brianne A Voros, Meghan Meadows-Taylor, et al.
British Journal of Cancer|July 20, 2001
Growing vascular endothelial cells express somatostatin subtype 2 receptorsJ C Watson, D A Balster, B M Gebhardt, et al.
Experimental Aging Research|February 9, 2023
Working Memory Precision and Associative Binding in Mild Cognitive ImpairmentYajun Jia, Steven Woltering, Nicolaas E P Deutz, et al.
Bioorganic & Medicinal Chemistry Letters|April 1, 2008
Synthesis and characterization of 1,3-dihydro-benzo[b][1,4]diazepin-2-one derivatives: Part 3. New potent non-competitive metabotropic glutamate receptor 2/3 antagonistsThomas J Woltering, Jürgen Wichmann, Erwin Goetschi, et al.
Health Physics|February 20, 1999
Experiences with high dose radiopeptide therapy: the health physics perspectiveG D Espenan, J A Nelson, D R Fisher, et al.
Pancreas|July 29, 2010
NANETS consensus guidelines for the diagnosis of neuroendocrine tumorAaron I Vinik, Eugene A Woltering, Richard R P Warner, et al.
Pancreas|November 1, 2005
Effect of octreotide LAR dose and weight on octreotide blood levels in patients with neuroendocrine tumorsEugene A Woltering, Paris M Mamikunian, Stanley Zietz, et al.
Journal of the American College of Surgeons|March 26, 2013
An extended phase II trial of iodine-125 methylene blue for sentinel lymph node identification in women with breast cancerWilliam W Harkrider, Anne E Diebold, Thomas Maloney, et al.
Pageof 43